Eicher Motors Q4 PAT rises 27% to ₹1,362 crore, board approves final dividend of ₹70


Royal Enfield recorded its highest-ever quarterly sales with 2,80,801 motorcycles, a 23.2% growth over Q4 FY24.

Royal Enfield recorded its highest-ever quarterly sales with 2,80,801 motorcycles, a 23.2% growth over Q4 FY24.
| Photo Credit: SHASHI ASHIWAL

Eicher Motors Ltd. (EML) for the quarter ended March 31, 2025 reported 27.3% Year-on-Year (YoY) growth in consolidated net profit at ₹1,362 crore backed by robust performance at Royal Enfield and Commercial Vehicles business. 

For the quarter, the company’s revenue from operations grew 23% YoY to ₹5,241 crore. 

Royal Enfield recorded its highest-ever quarterly sales with 2,80,801 motorcycles, a 23.2% growth over Q4 FY24.

For FY25 the company’s consolidated net profit grew 18.3% YoY to ₹4,734 crore. Revenue from operations at ₹18,870 crore, grew 14.1% YoY.

Royal Enfield recorded a landmark milestone, crossing 1 million annual sales for the first time. Total volumes stood at 1,002,893 units, up 10 YoY. Domestic sales grew 8.1% to 902,757 units, while international volumes grew 29.7%, with 100,136 motorcycles exported, the company said in a filing.

VE Commercial Vehicles (VECV) reported net profit of ₹1,286 crore on revenues of ₹23,548 crore, up 7.7% YoY. VECV sold 90,000 units in FY25, up 5.4% YoY. 

The Board has considered and recommended a final dividend of ₹70 per share (face value of ₹1 per share) for FY25 which is 34% higher than the previous year.

Siddhartha Lal, Chairman, Eicher Motors Ltd said, “We have had a remarkable year at EML and have reported exceptional performance across both Royal Enfield and VE Commercial Vehicles.”

“In the motorcycle business, the middleweight segment saw a lot of action from our peers. Remaining unfazed and maintaining focus on our strategic goals and community, Royal Enfield stood head and shoulders above everyone else to sell one million motorcycles annually, for the first time in its history,” he said. 

“At VECV also we saw record-breaking volumes and a strong performance despite the prevailing challenging market conditions. What excites me the most is that we have done it all quietly, consistently and with a sense of purpose.” 

“We balanced creativity with rigour, legacy and progress in a way that’s unique to our company and I genuinely believe we are just getting started,” he added.



Source link

  • Related Posts

    Lupin, China’s SUP ink pact for COPD drug Tiotropium DPI

    Lupin has signed a license and supply agreement with Sino Universal Pharmaceuticals (SUP) for commercialisation of chronic obstructive pulmonary disease drug Tiotropium Dry Powder Inhaler, 18 mcg/capsule, in the Chinese…

    Continue reading
    India to export 150 locomotives to Africa worth over ₹3,000 crore

    “These locomotives are fitted with Distributed Power Wireless Control System, or DPWCS, for synchronised operations and superior freight handling,” a Railways Ministry spokesperson said. Photo: https://www.wabteccorp.com/ India will supply 150…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *